Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+7.1%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$51.4B
AUM Growth
+$2.6B
(+5.3%)
Cap. Flow
+$799M
Cap. Flow
% of AUM
1.55%
Top 10 Holdings %
Top 10 Hldgs %
11.68%
Holding
2,449
New
226
Increased
917
Reduced
928
Closed
240
Top Buys
| 1 |
US Bancorp
USB
|
+$178M |
| 2 |
Truist Financial
TFC
|
+$132M |
| 3 |
BZUN
Baozun
BZUN
|
+$98.6M |
| 4 |
Crown Castle
CCI
|
+$98.4M |
| 5 |
StepStone Group
STEP
|
+$98.1M |
Top Sells
| 1 |
Alibaba
BABA
|
+$404M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$213M |
| 4 |
JPMorgan Chase
JPM
|
+$167M |
| 5 |
AT&T
T
|
+$133M |
Sector Composition
| 1 | Healthcare | 21.42% |
| 2 | Technology | 20.04% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
XP
XP
$9.84B
| $5.48M | 0.01% |
145,551
-22,443
| -13% | -$845K |
|
827
Stifel
SF
$11.6B
| $5.47M | 0.01% |
85,459
+1,323
| +2% | +$84.7K |
|
828
Booking.com
BKNG
$175B
| $5.47M | 0.01% |
2,349
+730
| +45% | +$1.7M |
|
829
Ironwood Pharmaceuticals
IRWD
$175M
| $5.45M | 0.01% |
487,388
-15,359
| -3% | -$172K |
|
830
MRC Global
MRC
$1.25B
| $5.45M | 0.01% |
603,394
-151,476
| -20% | -$1.37M |
|
|
DRNA
831
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.41M | 0.01% |
211,478
+211,208
| +78,225% | +$5.4M |
|
832
XPEL
XPEL
$1.02B
| $5.39M | 0.01% |
103,750
+38,023
| +58% | +$1.97M |
|
833
SS&C Technologies
SSNC
$21.6B
| $5.38M | 0.01% |
76,990
-389
| -0.5% | -$27.2K |
|
|
PFPT
834
DELISTED
Proofpoint, Inc.
PFPT
| $5.36M | 0.01% |
42,632
+29,491
| +224% | +$3.71M |
|
835
Bausch Health
BHC
$2.68B
| $5.34M | 0.01% |
168,200
+26,730
| +19% | +$848K |
|
836
Arcus Biosciences
RCUS
$1.21B
| $5.32M | 0.01% |
189,393
+188,881
| +36,891% | +$5.3M |
|
|
EGRX
837
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.3M | 0.01% |
126,849
+37,052
| +41% | +$1.55M |
|
838
Health Catalyst
HCAT
$233M
| $5.29M | 0.01% |
+113,164
| New | +$5.29M |
|
839
Omeros
OMER
$287M
| $5.28M | 0.01% |
+296,770
| New | +$5.28M |
|
|
SJR
840
DELISTED
Shaw Communications Inc.
SJR
| $5.23M | 0.01% |
199,421
-217,345
| -52% | -$5.7M |
|
841
Ranpak Holdings
PACK
$413M
| $5.22M | 0.01% |
+260,192
| New | +$5.22M |
|
842
MKS Inc. Common Stock
MKSI
$7.48B
| $5.2M | 0.01% |
28,021
+16,648
| +146% | +$3.09M |
|
843
CyberArk
CYBR
$23.8B
| $5.19M | 0.01% |
40,116
-1,115
| -3% | -$144K |
|
|
WLL
844
DELISTED
Whiting Petroleum Corporation
WLL
| $5.15M | 0.01% |
145,332
-495,982
| -77% | -$17.6M |
|
845
Lear
LEA
$5.78B
| $5.15M | 0.01% |
28,424
-2,238
| -7% | -$406K |
|
846
Ocular Therapeutix
OCUL
$2.24B
| $5.14M | 0.01% |
313,238
+64,327
| +26% | +$1.06M |
|
847
Macy's
M
$4.58B
| $5.13M | 0.01% |
316,906
-189,573
| -37% | -$3.07M |
|
848
Supernus Pharmaceuticals
SUPN
$2.56B
| $5.13M | 0.01% |
195,947
+14,480
| +8% | +$379K |
|
|
INOV
849
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $5.12M | 0.01% |
177,754
-170,415
| -49% | -$4.9M |
|
850
Modine Manufacturing
MOD
$7.94B
| $5.11M | 0.01% |
345,737
-13,075
| -4% | -$193K |
|